Event Group

Event Group

Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.

Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.

Event Group path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Group

Event Group


Ignite Creation Date: 2025-12-26 @ 5:22 PM
Ignite Modification Date: 2025-12-26 @ 5:22 PM
NCT ID: NCT05256706
Group ID: EG000
Title: SomaSignal Informed Medical Management SSCVD
Description: Blood draw for SSCVD test at baseline and 6 months (±50 days). SomaSignal Cardiovascular Risk (SSCVD) results will be sent to the providers and participants approximately 2-4 weeks after testing. SomaSignal Informed Medical Management SSCVD: For participants randomized to the Informed arm, the SSCVD test results will be provided to the participant's clinicians approximately 2-4 weeks after the baseline blood draw. Clinicians will discuss results with the participant and make adjustments to the care plan as needed based on the SSCVD test results within 50 days of receiving results. Clinicians may advise participants to (i) either change the doses of existing medications within existing guidelines, (ii) prescribe additional guideline-based medications, (iii) advise additional lifestyle interventions, or (iv) advise no change. This information will be documented in the case report forms. This test is neither intended to diagnose cardiovascular disease (CVD) nor replace the standard of care protocols for this disease. The physician should not rely solely on this information to make a decision on the best course of action for this patient.
Deaths Number Affected: 0
Deaths Number At Risk: None
Serious Number Affected: 1
Serious Number At Risk: 73
Other Number Affected: 0
Other Number At Risk: 73
Study: NCT05256706
Results Section: NCT05256706
Adverse Events Module: NCT05256706